<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>行舟Drug | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-14T02:41:19+08:00</updated>
  <subtitle>It takes nothing to join the crowd, but it takes everything to stand alone</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>重磅！《药品上市后变更管理办法》正式发布！即日起施行！！！</title>
    <updated>2021-01-13T19:54:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/86eyYZAPQcimWDTyhJdmpQ</id>
    <link href="https://mp.weixin.qq.com/s/86eyYZAPQcimWDTyhJdmpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>图解 | 一图读懂《药品上市后变更管理办法（试行）》</title>
    <updated>2021-01-13T19:54:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/i75FgyAME7M0zZvg_dyV_g</id>
    <link href="https://mp.weixin.qq.com/s/i75FgyAME7M0zZvg_dyV_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年生物药领域发展回顾</title>
    <updated>2021-01-13T19:54:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/v6PvbZUlCosGPN8B5tGupg</id>
    <link href="https://mp.weixin.qq.com/s/v6PvbZUlCosGPN8B5tGupg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物制品病毒安全性控制的核心理念探讨</title>
    <updated>2021-01-12T19:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/cD48dXE0pipnxq9yEz9aBQ</id>
    <link href="https://mp.weixin.qq.com/s/cD48dXE0pipnxq9yEz9aBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《药包材等同性/可替代性评价指南 》（征求意见稿）发布</title>
    <updated>2021-01-12T19:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/T4MDuJ1-109yuDTn-u90YQ</id>
    <link href="https://mp.weixin.qq.com/s/T4MDuJ1-109yuDTn-u90YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因治疗“从0到1”实现创新突破！病毒性角膜炎有望通过HELP疗法破解</title>
    <updated>2021-01-12T19:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/FHTRnS3VHJ-8rkyuZ1z3RQ</id>
    <link href="https://mp.weixin.qq.com/s/FHTRnS3VHJ-8rkyuZ1z3RQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告丨多肽药物非临床安全性评估的介绍</title>
    <updated>2021-01-12T19:42:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/UGF-OxaZa2dOXrqaMqFWMw</id>
    <link href="https://mp.weixin.qq.com/s/UGF-OxaZa2dOXrqaMqFWMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>收藏 | 26种仪器分析的原理及谱图方法大全</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/t-SAM-ylAjbnuCqIsjqN4w</id>
    <link href="https://mp.weixin.qq.com/s/t-SAM-ylAjbnuCqIsjqN4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何解读ICH指导原则中的杂质三限（报告限，鉴定限，界定限）</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/SmhuN9Vty6APiWwYygDNtg</id>
    <link href="https://mp.weixin.qq.com/s/SmhuN9Vty6APiWwYygDNtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药IND申报流程事宜图</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/Br9yySsUvGmsJw9SJiw9ow</id>
    <link href="https://mp.weixin.qq.com/s/Br9yySsUvGmsJw9SJiw9ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>器审中心 2020全年答疑汇总</title>
    <updated>2021-01-11T19:33:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/VBlsCdhlpc4LJBsb1Y0XFw</id>
    <link href="https://mp.weixin.qq.com/s/VBlsCdhlpc4LJBsb1Y0XFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>严重副作用不同疾病的对应手册（面向患者·公众）（52）-肺水肿</title>
    <updated>2021-01-10T19:42:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/dRiWrdMYad8AnLOUh6Yrmw</id>
    <link href="https://mp.weixin.qq.com/s/dRiWrdMYad8AnLOUh6Yrmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>请回答2020：中国创新药“后浪养成记”之新药研发交易篇</title>
    <updated>2021-01-10T19:42:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/BH9na6NXlQJvXmjOtPQEXg</id>
    <link href="https://mp.weixin.qq.com/s/BH9na6NXlQJvXmjOtPQEXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CFDI｜研发阶段的记录要求</title>
    <updated>2021-01-09T20:34:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/wPQhDKZHY3M13ZN-tmOfLw</id>
    <link href="https://mp.weixin.qq.com/s/wPQhDKZHY3M13ZN-tmOfLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞阿帕替尼肝癌适应症获批，未进临床路径药品或面临淘汰，三级医院将进行分类管理……</title>
    <updated>2021-01-09T20:34:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/N_wQh3yVDKFtXixde2ztfA</id>
    <link href="https://mp.weixin.qq.com/s/N_wQh3yVDKFtXixde2ztfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>62家药企宣布退市（附名单）</title>
    <updated>2021-01-09T20:34:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/9ZcvHQFVNbuWktGuHrQV2A</id>
    <link href="https://mp.weixin.qq.com/s/9ZcvHQFVNbuWktGuHrQV2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家文章｜生物类似药的研究进展及挑战</title>
    <updated>2021-01-08T20:42:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/1J0O9g_aeESr2bLn_mNX7A</id>
    <link href="https://mp.weixin.qq.com/s/1J0O9g_aeESr2bLn_mNX7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些重磅医药政策2021年开始实行！</title>
    <updated>2021-01-08T20:42:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/A4U8cHphOV1Sley1hEcZUQ</id>
    <link href="https://mp.weixin.qq.com/s/A4U8cHphOV1Sley1hEcZUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TIL免疫细胞疗法：击退肿瘤重燃生的希望！</title>
    <updated>2021-01-08T20:42:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/3G4yXBnWJw_sSr1-9Du-Aw</id>
    <link href="https://mp.weixin.qq.com/s/3G4yXBnWJw_sSr1-9Du-Aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专家文章｜我国药品上市许可持有人药物警戒职责分析</title>
    <updated>2021-01-07T20:19:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Enl81ZL0uVDr9tVXmllkXA</id>
    <link href="https://mp.weixin.qq.com/s/Enl81ZL0uVDr9tVXmllkXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>